Hypertension after preeclampsia and relation to the C1114G polymorphism (rs4606) in RGS2: data from the Norwegian HUNT2 study
- PMID: 24593135
- PMCID: PMC3973870
- DOI: 10.1186/1471-2350-15-28
Hypertension after preeclampsia and relation to the C1114G polymorphism (rs4606) in RGS2: data from the Norwegian HUNT2 study
Abstract
Background: Preeclampsia is associated with an increased risk of hypertension later in life. The regulator of G protein signaling 2 negatively regulates several vasoconstrictors. We recently demonstrated an association between preeclampsia and the CG or GG genotype of the C1114G polymorphism (rs4606) of the regulator of G protein signaling 2 gene. Here, we examined the polymorphism with respect to the development of hypertension after pregnancy.
Methods: We genotyped 934 women on average 15.1 years after preeclampsia and 2011 age matched women with previous normotensive pregnancy. All women in this study were retrospectively recruited from the Nord-Trøndelag Health Study (HUNT2). Information from HUNT2 was linked to the Medical Birth Registry of Norway to identify women with a history of preeclampsia and women without a history of preeclampsia.
Results: No significant association was found between hypertension (blood pressure ≥140/90 mmHg and/or taking antihypertensive drugs) and the polymorphism in crude analysis (OR (95% CI): CG genotype: 1.07 (0.90-1.27); GG genotype: 1.23 (0.90-1.67)). However, in a minimally adjusted model (age and BMI adjusted), a significant association between the GG genotype and hypertension was found (OR (95% CI): 1.49 (1.05-2.11)). This association remained significant also after adjustment for a history of preeclampsia (OR (95% CI): 1.46 (1.02-2.09)), but not in a model adjusted for multiple other variables (OR (95% CI): 1.26 (0.82-1.94)). In multivariate, but not in crude, analysis, the GG genotype of rs4606 (OR (95% CI): 1.93 (1.05-3.53)) was significantly and independently associated with severe hypertension later in life, defined as systolic blood pressure ≥160 mmHg (stage 2 hypertension) and/or taking antihypertensive drugs. A significant association was also found for the merged CG and GG genotypes (OR (95% CI): 1.43 (1.02-2.00)). Moreover, an interaction with physical activity was found. A history of preeclampsia was a significant and independent predictor of either definition of hypertension, both in crude and adjusted analyses.
Conclusion: Women carrying the rs4606 CG or GG genotype are at elevated risk for developing hypertension after delivery. Physical activity may interact with the association. Preeclampsia remains an independent risk factor for subsequent hypertension after adjusting for this polymorphism and classical CVD risk factors.
Similar articles
-
PP084. Hypertension after preeclampsia in women with C1114G polymorphism in rgs2 (the regulator of g protein signaling 2).Pregnancy Hypertens. 2013 Apr;3(2):98. doi: 10.1016/j.preghy.2013.04.109. Epub 2013 Jun 6. Pregnancy Hypertens. 2013. PMID: 26105937
-
Single nucleotide polymorphisms in G protein signaling pathway genes in preeclampsia.Hypertension. 2013 Mar;61(3):655-61. doi: 10.1161/HYPERTENSIONAHA.111.00331. Epub 2013 Jan 21. Hypertension. 2013. PMID: 23339167
-
An RGS2 3'UTR polymorphism is associated with preeclampsia in overweight women.BMC Genet. 2016 Aug 24;17(1):121. doi: 10.1186/s12863-016-0428-8. BMC Genet. 2016. PMID: 27558088 Free PMC article.
-
Association of Interleukin-10 -1082G > A Polymorphism with Susceptibility to Preeclampsia: A Systematic Review and Meta-Analysis Based on 21 Studies.Fetal Pediatr Pathol. 2020 Dec;39(6):518-532. doi: 10.1080/15513815.2019.1683919. Epub 2019 Nov 6. Fetal Pediatr Pathol. 2020. PMID: 31690147
-
The association of the prothrombin G20210A single-nucleotide polymorphism and the risk of preeclampsia: Systematic review and meta-analysis.Eur J Obstet Gynecol Reprod Biol. 2020 Oct;253:162-169. doi: 10.1016/j.ejogrb.2020.08.005. Epub 2020 Aug 25. Eur J Obstet Gynecol Reprod Biol. 2020. PMID: 32871439
Cited by
-
Regulator of G Protein Signaling 2: A Versatile Regulator of Vascular Function.Prog Mol Biol Transl Sci. 2015;133:77-92. doi: 10.1016/bs.pmbts.2015.02.001. Epub 2015 Apr 16. Prog Mol Biol Transl Sci. 2015. PMID: 26123303 Free PMC article. Review.
-
Vasopressin: the missing link for preeclampsia?Am J Physiol Regul Integr Comp Physiol. 2015 Nov 1;309(9):R1062-4. doi: 10.1152/ajpregu.00073.2015. Epub 2015 Mar 25. Am J Physiol Regul Integr Comp Physiol. 2015. PMID: 25810383 Free PMC article. Review.
-
Regulator of G Protein Signaling 2 Facilitates Uterine Artery Adaptation During Pregnancy in Mice.J Am Heart Assoc. 2019 May 7;8(9):e010917. doi: 10.1161/JAHA.118.010917. J Am Heart Assoc. 2019. PMID: 31030617 Free PMC article.
-
Regulators of G protein signaling in cardiovascular function during pregnancy.Physiol Genomics. 2018 Aug 1;50(8):590-604. doi: 10.1152/physiolgenomics.00037.2018. Epub 2018 Apr 27. Physiol Genomics. 2018. PMID: 29702036 Free PMC article. Review.
-
RGS2 promotes estradiol biosynthesis by trophoblasts during human pregnancy.Exp Mol Med. 2023 Jan;55(1):240-252. doi: 10.1038/s12276-023-00927-z. Epub 2023 Jan 18. Exp Mol Med. 2023. PMID: 36653442 Free PMC article.
References
-
- ACOG Committee on Obstetric Practice. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet. 2002;15:67–75. - PubMed
-
- Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007;15:974. doi: 10.1136/bmj.39335.385301.BE. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical